View More View Less
  • 1 University of Szeged
  • 2 University of Szeged
Open access

From year to year, it is important to get an overview of the occurrence of causative agents in febrile neutropenic patients to determine the empiric treatment. Thus our aims were to evaluate a four-year period regarding the prevalence of bloodstream infections and the most important causative agents. During this period, 1,361 patients were treated in our hematology ward because of various hematological disorders. 812 febrile episodes were recorded in 469 patients. At that time, 3,714 blood culture (BC) bottles were sent for microbiological investigations, 759 of them gave positive signal. From the majority of positive blood culture bottles (67.1%), Gram-positive bacteria, mainly coagulase-negative staphylococci (CNS), were grown. Gram-negative bacteria were isolated from 32.9% of the positive blood culture bottles, in these cases the leading pathogen was Escherichia coli. The high prevalence of CNS was attributed to mainly contamination, while lower positivity rate for Gram-negative bacteria was associated with the use of broad-spectrum empiric antibiotic treatment.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Crawford J , Dale DC, Lyman GH: Chemotherapy-induced neutropenia: risks, consequences, and new direction for its management. Cancer 100, 228237 (2004)

    • Search Google Scholar
    • Export Citation
  • 2.

    Madani TA : Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 28, 367373 (2000)

    • Search Google Scholar
    • Export Citation
  • 3.

    Peters RPH , van Agtmael MA, Danner SA, Savelkoul PHM, Vandenbroucke-Grauls CMJE: New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4, 751760 (2004)

    • Search Google Scholar
    • Export Citation
  • 4.

    Schimpff S , Satterlee W, Young VM et al.: Emipiric therapy with carbenicliin and gentamicin for febrile patients with cancer an granulocytopenia. N Engl J Med 284, 10611065 (1971)

    • Search Google Scholar
    • Export Citation
  • 5.

    Baden LR : Prophylactic antimicrobial agents and the importance of fitness. N Engl J Med 353, 10521054 (2005)

  • 6.

    Hammond SP , Baden LR: Antibiotic prophylaxis for patients with acute leukemia. Leuk Lymphoma 49, 183193 (2008)

  • 7.

    Hughes WT , Armstrong D, Bodey GP et al.: Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Inf Dis. 34, 730751 (2002)

    • Search Google Scholar
    • Export Citation
  • 8.

    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI document M100-S15 (ISBN 1-56238-556-9)

    • Search Google Scholar
    • Export Citation
  • 9.

    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. CLSI document M100-S16 (ISBN 1-56238-588-7)

    • Search Google Scholar
    • Export Citation
  • 10.

    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17 (ISBN 1-56238-625-5)

    • Search Google Scholar
    • Export Citation
  • 11.

    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100-S18 (ISBN 1-56238-653-0)

    • Search Google Scholar
    • Export Citation
  • 12.

    Mermel LA , Allon M, Bouza E et al.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49, 145 (2009)

    • Search Google Scholar
    • Export Citation
  • 13.

    Keng MK , Sekeres MA: Febrile neutropenia in hematologic malignancies. Curr Hematol Malig Rep 8, 370378 (2013)

  • 14.

    Bodey GP . Buckley M, Sathe YS, Freireich EY: Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med 64, 328340 (1966)

    • Search Google Scholar
    • Export Citation
  • 15.

    Syrjala H , Ohtonen P, Kinnunen U, Raty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itala-Remes M, Silvennoinen R, Koistinen P, Finnish Leukemia Group: Bloodstream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters. Eur J Clin Microbiol Infect Dis 29, 12111218 (2010)

    • Search Google Scholar
    • Export Citation
  • 16.

    Ramphal R : Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39, 2531 (2004)

    • Search Google Scholar
    • Export Citation
  • 17.

    Klastersky J , Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesamns M: Bacteremia in febrile neutropenic cancer patients. Int J Antimicrob Ag 30S, S51S59 (2007)

    • Search Google Scholar
    • Export Citation
  • 18.

    Viscoli C , Cometta A, Kern WV et al.: Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clin Microbiol Infect 12, 212216 (2006)

    • Search Google Scholar
    • Export Citation
  • 19.

    Winston DJ , Lazarus HM, Beveridge RA et al.: Randomized, double-blind, multicentre trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis 32, 381390 (2001)

    • Search Google Scholar
    • Export Citation
  • 20.

    DelFavero A , Menichetti F, Martino P et al.: A multicentre, double-bind, placebo-controlled trial comparing piperacillin–tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis 33, 12951301 (2001)

    • Search Google Scholar
    • Export Citation
  • 21.

    Cordonnier C , Buzyn A, Leverger G et al.: Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 36, 149158 (2003)

    • Search Google Scholar
    • Export Citation
  • 22.

    Picazo JJ : Management of the febrile neutropenic patient: a consensus conference. Clin Infect Dis 39, 16 (2004)

The author instruction is available in PDF.
Please, download the file from HERE.

 

MANUSCRIPT SUBMISSION

Language: English

Founded in 2011
Publication: One volume of four issues annually

Publication Programme: 2020. Vol. 10. (Online Only)

Article Processing Charge: EUR 600.00 (for discounts see the Open Access menu)

Indexing and Abstracting Services:

  • PubMed Central
  • ESCI

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com
You can find more information at http://eujmi.com